110 related articles for article (PubMed ID: 37979559)
1. Low expression of ZHX3 is associated with progression and poor prognosis in colorectal cancer.
Cai Z; Wang S; Zhou H; Cao D
Transl Oncol; 2024 Jan; 39():101829. PubMed ID: 37979559
[TBL] [Abstract][Full Text] [Related]
2. Attenuated ZHX3 expression serves as a potential biomarker that predicts poor clinical outcomes in breast cancer patients.
You Y; Ma Y; Wang Q; Ye Z; Deng Y; Bai F
Cancer Manag Res; 2019; 11():1199-1210. PubMed ID: 30787639
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of CPT2 promotes proliferation and inhibits apoptosis through p53 pathway in colorectal cancer.
Liu F; Li X; Yan H; Wu J; Yang Y; He J; Chen J; Jiang Z; Wu F; Jiang Z
Cell Signal; 2022 Apr; 92():110267. PubMed ID: 35108639
[TBL] [Abstract][Full Text] [Related]
4. Reticulocalbin 2 correlates with recurrence and prognosis in colorectal cancer.
Wang G; Wang Q; Fan Y; He X
Am J Cancer Res; 2017; 7(11):2169-2179. PubMed ID: 29218241
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of UQCRC2 is correlated with tumor progression and poor prognosis in colorectal cancer.
Shang Y; Zhang F; Li D; Li C; Li H; Jiang Y; Zhang D
Pathol Res Pract; 2018 Oct; 214(10):1613-1620. PubMed ID: 30115536
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value and therapeutic implications of ZHX family member expression in human gastric cancer.
You Y; Bai F; Li H; Ma Y; Yao L; Hu J; Tian Y
Am J Transl Res; 2020; 12(7):3376-3388. PubMed ID: 32774706
[TBL] [Abstract][Full Text] [Related]
7. Attenuated ZHX3 expression is predictive of poor outcome for liver cancer: Indication for personalized therapy.
You Y; Hu F; Hu S
Oncol Lett; 2022 Jul; 24(1):224. PubMed ID: 35720472
[TBL] [Abstract][Full Text] [Related]
8. TEAD4 nuclear localization and regulation by miR-4269 and miR-1343-3p in colorectal carcinoma.
Bhat IP; Rather TB; Bhat GA; Maqbool I; Akhtar K; Rashid G; Parray FQ; Besina S; Mudassar S
Pathol Res Pract; 2022 Mar; 231():153791. PubMed ID: 35124548
[TBL] [Abstract][Full Text] [Related]
9. Elevated CD163
Yang C; Wei C; Wang S; Shi D; Zhang C; Lin X; Dou R; Xiong B
Int J Biol Sci; 2019; 15(5):984-998. PubMed ID: 31182919
[No Abstract] [Full Text] [Related]
10. Expression of long non-coding RNA PANDAR and its prognostic value in colorectal cancer patients.
Li X; Wang F; Sun Y; Fan Q; Cui G
Int J Biol Markers; 2017 May; 32(2):e218-e223. PubMed ID: 28106228
[TBL] [Abstract][Full Text] [Related]
11. Expression and clinical significance of absent in melanoma 2 in colorectal cancer.
Zhang Z; Dong X; Yang X; Wan D; Sun L; Gu M; Li M; Zhu Z; Wang J; Shang Z; He S
Biomed Pharmacother; 2017 Oct; 94():843-849. PubMed ID: 28802238
[TBL] [Abstract][Full Text] [Related]
12. Abnormal expression of calcyphosine is associated with poor prognosis and cell biology function in colorectal cancer.
Shao W; Wang Q; Wang F; Jiang Y; Xu M; Xu J
Onco Targets Ther; 2016; 9():477-87. PubMed ID: 26889086
[TBL] [Abstract][Full Text] [Related]
13. The high expression of long non-coding RNA PANDAR indicates a poor prognosis for colorectal cancer and promotes metastasis by EMT pathway.
Lu M; Liu Z; Li B; Wang G; Li D; Zhu Y
J Cancer Res Clin Oncol; 2017 Jan; 143(1):71-81. PubMed ID: 27629879
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of DSCR1 prevents proliferation and predicts favorable prognosis in colorectal cancer patients.
Li WX; Zheng JJ; Zhao G; Lyu CT; Lu WQ
World J Surg Oncol; 2021 Apr; 19(1):100. PubMed ID: 33827593
[TBL] [Abstract][Full Text] [Related]
15. Expression of SATB1 promotes the growth and metastasis of colorectal cancer.
Zhang Y; Tian X; Ji H; Guan X; Xu W; Dong B; Zhao M; Wei M; Ye C; Sun Y; Yuan X; Yang C; Hao C
PLoS One; 2014; 9(6):e100413. PubMed ID: 24971456
[TBL] [Abstract][Full Text] [Related]
16. Association between KIAA1199 overexpression and tumor invasion, TNM stage, and poor prognosis in colorectal cancer.
Xu J; Liu Y; Wang X; Huang J; Zhu H; Hu Z; Wang D
Int J Clin Exp Pathol; 2015; 8(3):2909-18. PubMed ID: 26045799
[TBL] [Abstract][Full Text] [Related]
17. Bromodomain-containing protein 9 activates proliferation and epithelial-mesenchymal transition of colorectal cancer via the estrogen pathway
Chen P; Du R; Chang Z; Gao W; Zhao W; Dong G
J Gastrointest Oncol; 2023 Apr; 14(2):980-996. PubMed ID: 37201092
[TBL] [Abstract][Full Text] [Related]
18. High Expression Level of TRIP6 is Correlated with Poor Prognosis in Colorectal Cancer and Promotes Tumor Cell Proliferation and Migration.
Ren H; Su Z; Yang J; Cao J; Zhang Y; Sheng K; Guo K; Wang Y
Biochem Genet; 2024 Mar; ():. PubMed ID: 38430448
[TBL] [Abstract][Full Text] [Related]
19. CXCL10 expression and prognostic significance in stage II and III colorectal cancer.
Jiang Z; Xu Y; Cai S
Mol Biol Rep; 2010 Jul; 37(6):3029-36. PubMed ID: 19821051
[TBL] [Abstract][Full Text] [Related]
20. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
